Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases.
Hammang
J P
JP
CytoTherapeutics, Inc., Providence, RI 02906, USA.
Emerich
D F
DF
Winn
S R
SR
Lee
A
A
Lindner
M D
MD
Gentile
F T
FT
Doherty
E J
EJ
Kordower
J H
JH
Baetge
E E
EE
D000180:Acrylic Resins; D000544:Alzheimer Disease / Q000628:therapy; D000818:Animals; D001704:Biopolymers; D001927:Brain Diseases / Q000628:therapy*; D002460:Cell Line; D017690:Cell Transplantation / Q000379:methods*; D002795:Choline O-Acetyltransferase / Q000032:analysis; D006224:Cricetinae; D007839:Functional Laterality; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D007668:Kidney; D008252:Macaca fascicularis; D009414:Nerve Growth Factors / Q000096:biosynthesis*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D010300:Parkinson Disease / Q000628:therapy; D011143:Polyvinyl Chloride; D016548:Prosencephalon; D017475:Receptors, Nerve Growth Factor / Q000032:analysis; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D013762:Tetrahydrofolate Dehydrogenase / Q000096:biosynthesis; D014162:Transfection
D000180:Acrylic Resins; D001704:Biopolymers; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D017475:Receptors, Nerve Growth Factor; D011993:Recombinant Fusion Proteins; C086656:polyacrylonitrile-polyvinylchloride; D011143:Polyvinyl Chloride; D013762:Tetrahydrofolate Dehydrogenase; D002795:Choline O-Acetyltransferase